Search

everythinglearnresearchcommunity

for

Search:↓

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Acne is an important sign of androgen excess disorders in women.

Both genetic and lifestyle factors significantly affect female hair loss.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Finasteride exposure harms tadpole reproduction and hormone balance.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The entry showed that PCOS negatively affects women's self-image and is worsened by societal expectations, suggesting a need for more feminist attention to the condition.

Acne significantly affects both physical health and mental well-being.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Environmental factors like temperature and nutrition affect hair growth, with humans showing seasonal hair growth differences.

Eating dairy and high glycemic foods may increase the risk of acne.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.